OKYO Pharma
pipeline focus to treat dry eye disease | OKYO Pharma
Company
Deck Type
Sector
Industry
Deck date
June 2023
Slide
4 of 25
Related slides by other companies
NeuroSense Therapeutics
Investor Presentation
October 2024
focused pipeline go | NeuroSense Therapeutics
RenovoRx
IPO
August 2021
designed for success one phase trial to approval pivotal tiger pac phase study schema currently enrolling | RenovoRx
NeuroBo Pharmaceuticals
Investor Presentation
December 2023
pipeline a mash obesity | NeuroBo Pharmaceuticals
GH Research
Investor Presentation
March 2023
phase trial in treatment resistant depression completed | GH Research
Other recent decks by OKYO Pharma
See all presentations (2 decks)
Shareholder Engagement
March 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights